- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.46 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x MG: MAGNESIUM ION(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
ZN.3: 5 residues within 4Å:- Chain A: H.100, H.136, D.137, D.254
- Ligands: MG.1
6 PLIP interactions:4 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:H.100, A:H.136, A:D.137, A:D.254, H2O.1, H2O.4
ZN.12: 5 residues within 4Å:- Chain B: H.100, H.136, D.137, D.254
- Ligands: MG.11
6 PLIP interactions:4 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:H.100, B:H.136, B:D.137, B:D.254, H2O.11, H2O.13
- 2 x AH6: 6-ethoxy-7-methoxy-3,4-dihydroisoquinoline-2(1H)-carbaldehyde(Non-covalent)
AH6.4: 9 residues within 4Å:- Chain A: N.257, Y.265, W.268, T.269, I.272, F.276, M.293, Q.305, F.308
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:N.257, A:Y.265, A:W.268, A:I.272, A:F.276
- Hydrogen bonds: A:Q.305
- pi-Stacking: A:F.308
AH6.13: 9 residues within 4Å:- Chain B: N.257, Y.265, W.268, T.269, I.272, F.276, M.293, Q.305, F.308
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:N.257, B:Y.265, B:W.268, B:I.272, B:I.272, B:F.276
- Hydrogen bonds: B:Q.305
- pi-Stacking: B:F.308
- 11 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.5: 4 residues within 4Å:- Chain A: K.198, I.201, D.202
- Chain B: N.160
4 PLIP interactions:1 interactions with chain B, 3 interactions with chain A- Water bridges: B:D.161, A:D.202
- Hydrogen bonds: A:K.198, A:D.202
EDO.6: 3 residues within 4Å:- Chain A: D.337, N.338, W.341
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.338
EDO.7: 5 residues within 4Å:- Chain A: S.144, F.276, S.291, P.292, C.294
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:S.144, A:S.144, A:P.292
- Water bridges: A:Q.279
EDO.8: 5 residues within 4Å:- Chain A: F.174, F.185, R.193, L.196, R.197
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.193
- Water bridges: A:R.193, A:R.197
EDO.9: 6 residues within 4Å:- Chain A: T.70, F.71, K.72, N.187, L.188, Q.192
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.192, A:Q.192
EDO.10: 8 residues within 4Å:- Chain A: V.110, L.111, T.114, W.320, V.324, D.327, A.328, I.331
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:V.110, A:T.114, A:W.320
EDO.14: 5 residues within 4Å:- Chain B: S.144, F.276, S.291, P.292, C.294
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:S.144, B:S.144, B:P.292
- Water bridges: B:Q.279
EDO.15: 5 residues within 4Å:- Chain A: N.160, S.162
- Chain B: K.198, I.201, D.202
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain B- Water bridges: A:D.161, A:S.162
- Hydrogen bonds: B:D.202
EDO.16: 1 residues within 4Å:- Chain B: P.347
No protein-ligand interaction detected (PLIP)EDO.17: 3 residues within 4Å:- Chain B: L.262, D.337, W.341
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:D.337
- Water bridges: B:W.341
EDO.18: 5 residues within 4Å:- Chain B: E.86, D.87, Y.89, A.91, N.98
4 PLIP interactions:4 interactions with chain B- Water bridges: B:D.87, B:D.87, B:Y.89, B:N.98
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, X. et al., Structure-Aided Identification and Optimization of Tetrahydro-isoquinolines as Novel PDE4 Inhibitors Leading to Discovery of an Effective Antipsoriasis Agent. J.Med.Chem. (2019)
- Release Date
- 2019-10-23
- Peptides
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.46 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x MG: MAGNESIUM ION(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x AH6: 6-ethoxy-7-methoxy-3,4-dihydroisoquinoline-2(1H)-carbaldehyde(Non-covalent)
- 11 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, X. et al., Structure-Aided Identification and Optimization of Tetrahydro-isoquinolines as Novel PDE4 Inhibitors Leading to Discovery of an Effective Antipsoriasis Agent. J.Med.Chem. (2019)
- Release Date
- 2019-10-23
- Peptides
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B